Clinical Trials Browser

Cetuximab × Sarcoma × 90 days × Clear all

NCT06865664 2026-03-16

FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma

Phase 1 Recruiting

Rhabdomyosarcoma, Sarcoma

NCT05041127 2026-02-19

Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma

Phase 2 Active not recruiting

Chordoma